An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease.

Horvath S1,2, Gurven M3, Levine ME4, Trumble BC3, Kaplan H5, Allayee H6, Ritz BR7, Chen B8, Lu AT4, Rickabaugh TM9, Jamieson BD9, Sun D10, Li S10,Chen W10, Quintana-Murci L11, Fagny M12, Kobor MS13, Tsao PS14,15, Reiner AP16, Edlefsen KL17, Absher D18, Assimes TL14.

Author information

Abstract

BACKGROUND:

Epigenetic biomarkers of aging (the "epigenetic clock") have the potential to address puzzling findings surrounding mortality rates and incidence of cardio-metabolic disease such as: (1) women consistently exhibiting lower mortality than men despite having higher levels of morbidity; (2) racial/ethnic groups having different mortality rates even after adjusting for socioeconomic differences; (3) the black/white mortality cross-over effect in late adulthood; and (4) Hispanics in the United States having a longer life expectancy than Caucasians despite having a higher burden of traditional cardio-metabolic risk factors.

RESULTS:

We analyzed blood, saliva, and brain samples from seven different racial/ethnic groups. We assessed the intrinsic epigenetic age acceleration of blood (independent of blood cell counts) and the extrinsic epigenetic aging rates of blood (dependent on blood cell counts and tracks the age of the immune system). In blood, Hispanics and Tsimane Amerindians have lower intrinsic but higher extrinsic epigenetic aging rates than Caucasians. African-Americans have lower extrinsic epigenetic aging rates than Caucasians and Hispanics but no differences were found for the intrinsic measure. Men have higher epigenetic aging rates than women in blood, saliva, and brain tissue.

CONCLUSIONS:

Epigenetic aging rates are significantly associated with sex, race/ethnicity, and to a lesser extent with CHD risk factors, but not with incident CHD outcomes. These results may help elucidate lower than expected mortality rates observed in Hispanics, older African-Americans, and women.